ArticleJournal of the National Cancer Institute2024

Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.

Jung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.